NewLimit
Extending human healthspan.
NewLimit is a 11-50-employee Biotechnology Research company based in San Francisco, California. Founded in 2022. Has raised $435M, most recently at the Series C stage. Its most recent round on file is dated Jun 2, 2026. Adamlead has 1 contact on file at NewLimit.
Company details
Tech stack
Not on file.
People at NewLimit
| Name | Title | |
|---|---|---|
 Blake Byers | Co-Founder | b***@newlimit.comVerified |
Open roles at NewLimit
Read directly off NewLimit's own careers page — Adamlead doesn't write job descriptions, so if a role looks stale it may already be filled there.
Companies similar to NewLimit
Frequently asked questions
When did NewLimit last raise funding?+
NewLimit's most recent round on file is dated Jun 2, 2026, at the Series C stage. Total funding on file: $435M.
How many contacts does Adamlead have for NewLimit?+
We have 1 contact on file for NewLimit. Each email shows its verification status and a confidence score.
What industry is NewLimit in?+
NewLimit is categorized under Biotechnology Research on Adamlead, alongside 17 other companies in the segment.
Can I get verified emails for people at NewLimit?+
Yes. Start a 7-day free trial and reveal any contact's email for one credit. Every address carries a confidence score, and revealing the same contact again is always free.
What companies are similar to NewLimit?+
Other Biotechnology Research startups on Adamlead, closest first by funding stage, include Loyal, Hemab Therapeutics, A2 Biotherapeutics. See the list below for more.
Is NewLimit hiring?+
Yes — we found 3 open roles on NewLimit's own careers page. See the list below; each one links to where to apply.
Reveal verified contacts at NewLimit
NewLimit raised on Jun 2, 2026 — reach out while the budget is fresh. 7-day free trial, no card required.
Start free trial